Cuba vs Germany: Life science patents granted, by technology
Cuba
17 patents
in 2023
Germany
18 patents
in 2023
Cuba rank
31st
Germany rank
30th
Life science patents granted, by technology over time
- Cuba
- Germany
How they compare
Germany currently reports 18 patents against 17 patents in Cuba, a difference of 1 patents.
That makes Germany's figure about 1.1 times Cuba's.
The two have swapped places 4 times across 26 shared years of data; in 1987 it was Germany ahead.
Cuba ranks 31st and Germany ranks 30th of 65 countries.
Across the 5 decades both report, Cuba averaged higher in 2 and Germany in 3.
Head to head by decade
| Decade | Cuba | Germany | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2 patents | 235.5 patents | 233.5 patents | Germany |
| 1990s | 1 patents | 100 patents | 99 patents | Germany |
| 2000s | 9.38 patents | 76.75 patents | 67.38 patents | Germany |
| 2010s | 27.5 patents | 23.3 patents | 4.2 patents | Cuba |
| 2020s | 20.25 patents | 17.5 patents | 2.75 patents | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Cuba or Germany?
- Germany, at 18 patents against 17 patents in Cuba as of 2023.
- What is the difference in life science patents granted, by technology between Cuba and Germany?
- 1 patents, with Germany ahead.
- How many years of comparable data are there for Cuba and Germany?
- 26 years are reported by both, from 1987 to 2023.
- How do Cuba and Germany rank globally for life science patents granted, by technology?
- Cuba ranks 31st and Germany ranks 30th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.